EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

THE PERFORMANCE OF NUCLEIC ACID AMPLIFICATION TESTS FOR THE DIAGNOSIS OF TUBERCULOSIS AND RESISTANCE TO RIFAMPICIN IN DOTS CENTRES OF A DISTRICT IN SOUTH INDIA

Rebecca Ann Jose, Dr. Jijo Oommen Roy, Dr. Anna Mathew*, Nisha M. and John Michael Raj

ABSTRACT

Title of Study: The Performance of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis and resistance to rifampicin in DOTS centres of a district in South India. Background and Objectives: According to WHO the number of new tuberculosis (TB) cases reported in India in 2017 was 2740 and the rate of incidence of MDR-TB was 10/100,000 population. Early diagnosis facilitates treatment initiation and can limit the spread of the disease. The Revised National Tuberculosis Programme (RNTCP) has scaled up the use of the Cartridge Based Nucleic Acid Amplification Test (CBNAAT), also known as GeneXpert, and provides it free of cost to the patient. In addition to the existing 628 Machines, 507 machines have been deployed to cover all districts of the entire country. The CBNAAT is provided free of cost This study was undertaken to assess the performance of the CB-NAAT test in peripheral DOTS centres of this predominantly rural district. Methods: The diagnostic accuracy of the CB-NAAT test in diagnosing tuberculosis in patients presenting at the various DOTS centres of this district was assessed. After approval from ethics committee and written permission from the district tuberculosis officer, patients suspected to have tuberculosis, registered at the DOTS clinic for CB-NAAT 178 participants were serially recruited. Results: Of the 178 samples studied, 81 (45.5%) had a positive CBNAAT, while 71 (39.9%) had positive smear microscopy. The remaining 107 smear samples and 97 CBNAAT samples were negative. Of the 81 mycobacteria positive samples diagnosed by CBNAAT, 62 were also diagnosed by smear microscopy, giving a sensitivity of 87.3% while 19 cases identified by CBNAAT were sputum smear negative. Of the 107 smear microscopy negative samples, CBNAAT was negative in 91 subjects giving a specificity of 82.2%. The high positive predictive value (85.2%) indicates the strong probability that a person with a positive test has tuberculosis. The high negative predictive value (95.7%) shows that a negative test in effect rules out tuberculosis. The high likelihood ratio of nearly 5 with a confidence interval of 3.24 to 7.46 tells us that the test has a high probability to identify the presence of mycobacteria. Interpretation & Conclusions: The sensitivity of the CB-NAAT test obtained in our study was 87.3% and specificity was 82.20%. Rifampicin resistance was present in less than one-tenth of the samples (7.3%). The study showed that CB-NAAT is an equally sensitive and specific rapid molecular diagnostic test to detect TB and rifampicin resistance in biological specimens in patients suspected to have tuberculosis.

Keywords: Diagnosis of Tuberculosis, Gene expert, CB-NAAT, rifampicin resistance, sputum microscopy.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 December 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: DECEMBER ISSUE PUBLISHED

    DECEMBER Issue has been successfully launched on 1 December 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )